You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

systemic embolism

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism Trial (WATCHMAN device)

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • WATCHMAN device
  • (no location specified)
Jul 18, 2023

Stroke or Systemic Embolism in Chinese Non-Valvular Atrial

Not yet recruiting
  • Atrial Fibrillation
  • Stroke
    • (no location specified)
    Oct 26, 2022

    Stroke and Systemic Embolism in Atrial Fibrillation in Real-Life

    Completed
    • Anticoagulation
    • Rueil-malmaison Cedex, France
      (unnamed)
    May 16, 2022

    Ischemic Stroke, Systemic Embolism Trial (AtriClip LAA Exclusion System)

    Not yet recruiting
    • Ischemic Stroke
    • Systemic Embolism
    • AtriClip LAA Exclusion System
    • (no location specified)
    Jul 26, 2022

    NOAC Portuguese Real World Study

    Withdrawn
    • Stroke
    • +2 more
    • (no location specified)
    Apr 8, 2022

    Stroke and Non-Central Nervous Systemic Embolism in Renally

    Completed
    • Non-valvular Atrial Fibrillation (NVAF)
    • Rivaroxaban(Xarelto,BAY 59-7939)
    • Multiple Locations, Korea, Republic of
      Many locations
    Dec 21, 2021

    Gain Information on Drug Xarelto for Prevention of Brain Attack

    Completed
    • Non-valvular Atrial Fibrillation (NVAF)
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Multiple Locations, Taiwan
      Many Locations
    Jan 29, 2023

    Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism Trial in Bay Shore, Queens (Alteplase, EKOS)

    Active, not recruiting
    • Pulmonary Embolism
    • +3 more
    • Bay Shore, New York
    • +1 more
    Apr 4, 2022

    Mitral Valve Stenosis, Atrial Fibrillation, Stroke Trial in Korea, Republic of (Edoxaban, Warfarin)

    Recruiting
    • Mitral Valve Stenosis
    • +3 more
    • Seoul, Seocho-gu, Korea, Republic of
    • +6 more
    Sep 12, 2022

    Cerebral Stroke, Thrombosis, Deep Vein, Pulmonary Embolism Trial

    Withdrawn
    • Cerebral Stroke
    • +2 more
      • (no location specified)
      Nov 14, 2021

      Pulmonary Embolism, Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Tucson (Catheter directed

      Recruiting
      • Pulmonary Embolism
      • +2 more
      • Catheter directed therapy
      • Systemic anticoagulation
      • Tucson, Arizona
        Banner University Medical Center
      Sep 21, 2022

      Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin

      Completed
      • Venous Thromboembolism
      • +3 more
      • Rivaroxaban 20 MG [Xarelto]
      • +2 more
      • Metepec, Estado De Mexico, Mexico
        Instituto Mexicano Del Seguro Social
      Aug 24, 2022

      Stroke and Noncentral Nervous System Systemic Embolism in

      Completed
      • Atrial Fibrillation
      • Rivaroxaban (Xarelto, BAY59-7939)
      • Multiple Locations, Korea, Republic of
      • +1 more
      Nov 20, 2020

      Patent Foramen Ovale, Embolism Trial in Czechia (Cardiac flow measurement)

      Recruiting
      • Patent Foramen Ovale
      • Embolism
      • Cardiac flow measurement
      • Brno, Czechia
      • +5 more
      Oct 29, 2020

      Stroke and Non-central Nervous System Systemic Embolism in

      Completed
      • Stroke
      • Rivaroxaban (Xarelto, BAY 59-7939)
      • HangZhou, China
        (unnamed)
      Sep 2, 2020

      Coronary Artery Bypass Grafting, Postoperative Atrial Fibrilation, Stroke Trial in Fargo (Apixaban, Warfarin)

      Completed
      Has Results
      • Coronary Artery Bypass Grafting
      • +4 more
      • Fargo, North Dakota
        Sanford Health
      Dec 28, 2020

      Non-paroxysmal Atrial Fibrillation Trial in Beijing (Thoracoscopic LAA clipping, Novel oral anticoagulant)

      Not yet recruiting
      • Non-paroxysmal Atrial Fibrillation
      • Thoracoscopic LAA clipping
      • Novel oral anticoagulant
      • Beijing, Beijing, China
        China National Center for Cardiovascular Diseases
      Aug 31, 2023

      Atrial Fibrillation (AF) Trial in Johns Creek, Charlotte, Lenoir (Abelacimab, Placebo)

      Recruiting
      • Atrial Fibrillation (AF)
      • Abelacimab
      • Placebo
      • Johns Creek, Georgia
      • +2 more
      Jan 25, 2023

      Left Atrial Appendage Closure as Secondary Prevention of Atrial

      Recruiting
      • Non-valvular Atrial Fibrillation
      • Embolic Stroke
      • Transthoracic Echocardiography
      • Jinan, Shandong, China
      • +4 more
      Dec 15, 2022

      Arterial Embolism After Catheter Ablation of Atrial

      Not yet recruiting
      • Arrhythmia
      • +5 more
      • No intervention.
      • (no location specified)
      Nov 11, 2023

      Keeping Oral o Parental AnticoaguLation in Acute Phase of

      Recruiting
      • Cardioembolic Stroke
      • +3 more
      • Observation
      • Paris, France
      • +2 more
      Aug 2, 2022

      Atrial Fibrillation Trial in Xi'an (Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg)

      Recruiting
      • Atrial Fibrillation
      • Rivaroxaban 15mg
      • +4 more
      • Xi'an, Shannxi, China
        Ling Tao
      Jul 24, 2023

      Left Atrial Appendage Closure Registry of Henri Mondor Hospital

      Not yet recruiting
      • Atrial Fibrillation
      • SA brief descriptive name used to refer to the intervention(s) studied
      • Créteil, France
        Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
      Oct 3, 2022

      Surgery in Pulmonary Embolisms

      Not yet recruiting
      • Pulmonary Embolism
      • surgical pulmonary embolectomy
      • (no location specified)
      Sep 30, 2023

      Aortic Valve Disease Trial in Paris (Apixaban 5 MG Oral Tablet, warfarin with an objective of INR target of 2.5 (range:

      Not yet recruiting
      • Aortic Valve Disease
      • Apixaban 5 MG Oral Tablet
      • warfarin with an objective of INR target of 2.5 (range: 2.0-3.0)
      • Paris, France
        Service de Cardiologie Hôpital Lariboisière
      Jan 24, 2023